Summary: Endovascular coil emobolization has emerged as an alternative treatment of ruptured intracranial aneurysms, and it has reduced the therapeutic assault on vessels. However, it is not clear what happens between such therapeutic assault and vascular response on a molecular level. We investigated endothelial cell disorder after subarachnoid hemorrhage (SAH) and the impact of open and endovascular surgery.
what happens between such therapeutic assault and vascular response on a molecular level. We investigated endothelial cell disorder after subarachnoid hemorrhage (SAH) and the impact of open and endovascular surgery.
In rat SAH models, we confirmed the endothelial perturbation such as the expression of interleukin 1-β, plasminogen actibator inhibitor-1 (PAI-1), von Willebrand factor (vWF), E-selectin, and apoptosis-related products that caused the morphological changes of endothelial cells. In a real-time RT-PCR study, direct brain damage by a cold injury after experimental SAH emphasized the expression of p38 mitogen-activated protein kinase (p38 MAPK) in endothelial cells.
In 36 SAH patients, the serum markers of endothelial cell disorder such as PAI-1, vWF and E-selectin that exist in the lower stream of p38 MAPK were compared between endovascular coil embolization Normal range of serum E-selectin is between 29.1 ng/ml and 63.4 ng/ml. Serum levels of E-selectin in open surgery were higher than endovascular surgery between 0 and 14 days following SAH, and the difference was significant on day 7 (63.6 37.6 ng/ml vs. 40.8 24.7 ng/ml, p 0.039).
Fig. 6
Sequential changes of serum plasminogen inhibitor-1 (PAI-1) after open and endovascular surgery. Normal range of plasma PAI-1 is below 50 ng/ml. Serum levels of PAI-1 after open surgery were over 50 ng/ml between 0 to 14 days whereas those after endovascular surgery were within the normal range. Difference was significant on day 7 (65.2 49.1 ng/ml vs. 32.3 12.5 ng/ml, p 0.0125) and day 14 (63.67 27.4 ng/ml vs. 39.3 13.3 ng/ml, p 0.002). 
